Position in NVS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,730,972
-$451,234 QoQ
Shares Held
11,045
-30.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#469
of 1,603 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $41,461,553,100 across 12 Drug Manufacturers - General names. NVS ranks #12 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,998,953 | $13,192,475,293 | |
| 2 | MRK |
Merck & Co., Inc.
|
86,249,283 | $11,083,032,864 | |
| 3 | JNJ |
Johnson & Johnson
|
22,588,696 | $5,736,851,118 | |
| 4 | AZN |
Astrazeneca PLC
|
28,537,243 | $5,411,232,013 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
12,699,683 | $1,604,477,945 | |
| 6 | ABBV |
AbbVie Inc.
|
5,055,589 | $1,272,188,413 | |
| 7 | AMGN |
Amgen Inc
|
2,742,271 | $993,031,171 | |
| 8 | BIIB |
Biogen Inc.
|
3,117,469 | $673,560,350 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,730,972 | 11,045 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $2,182,206 | 15,828 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $180,060,244 | 1,404,088 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $302,814,817 | 2,502,395 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $333,473,021 | 2,991,326 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $354,973,350 | 3,647,861 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $459,985,105 | 3,999,175 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $466,789,835 | 4,384,650 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $443,927,822 | 4,589,350 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $479,264,097 | 4,746,599 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $477,918,560 | 4,691,916 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $479,519,473 | 4,751,952 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $446,612,620 | 4,854,485 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $440,391,798 | 4,854,407 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $386,708,623 | 5,087,602 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $389,304,771 | 4,605,522 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $362,577,294 | 4,131,935 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $358,316,653 | 4,096,452 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $344,697,136 | 4,214,932 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $316,582,269 | 3,469,775 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $330,540,985 | 3,866,881 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $323,237,665 | 3,423,040 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $251,547,277 | 2,892,678 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $322,698,763 | 3,694,742 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $253,810,531 | 3,078,357 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||